Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients (ITX5061)

This study has been completed.
Sponsor:
Collaborators:
University Hospital Birmingham
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
University of Birmingham
ClinicalTrials.gov Identifier:
NCT01292824
First received: February 9, 2011
Last updated: December 1, 2015
Last verified: December 2015